Gastric Inhibitory Polypeptide
Showing 1 - 25 of 5,990
Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
-
Al Ain, Abu Dhabi, United Arab EmiratesInternal Medicine, College of Medicine and Health Sciences
Mar 1, 2023
Healthy Trial in Oxford (25 g Nutralys Pea Protein, 50 g Nutralys S85 Plus., 50 g Glucose)
Completed
- Healthy
- 25 g Nutralys Pea Protein
- +2 more
-
Oxford, United KingdomOxford Brookes Centre for Nutrition and Health
Oct 29, 2020
Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide
Recruiting
- Type 2 Diabetes
- Obesity
- Semaglutide 1.34 MG/ML [Ozempic]
- +3 more
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
May 19, 2022
Childhood Obesity Trial (Meal replacement and lifestyle modification)
Not yet recruiting
- Childhood Obesity
- Meal replacement and lifestyle modification
- (no location specified)
Jan 10, 2023
Type 2 Diabetes Trial in Nottingham (BetaQuik™, WheyBasics, Iso-voluminous water)
Completed
- Type 2 Diabetes
- BetaQuik™
- +2 more
-
Nottingham, United KingdomUniversity of Nottingham
Aug 15, 2022
Hypertriglyceridemia Trial in Hellerup (DHA-NAT, Placebo)
Recruiting
- Hypertriglyceridemia
- DHA-NAT
- Placebo
-
Hellerup, DenmarkCenter for Clinical Metabolic Research, Herlev-Gentofte Hospital
Jul 11, 2023
Obesity Trial (LaKe Ester, Placebo)
Not yet recruiting
- Obesity
- LaKe Ester
- Placebo
- (no location specified)
Jun 14, 2023
Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)
Completed
- Bariatric Surgery
- Placebo
- +3 more
-
Hvidovre, Denmark
- +1 more
Jan 31, 2022
Blood Glucose Fluctuations, Hunger Trial in Vienna (Sucrose, Hesperetin)
Not yet recruiting
- Blood Glucose Fluctuations
- Hunger
- Sucrose
- Hesperetin
-
Vienna, AustriaChristian Doppler Laboratory for Taste Research
Jan 26, 2023
Type 2 Diabetes, Ketoses, Metabolic Trial in Aarhus (3-hydroxybutyrate)
Recruiting
- Type 2 Diabetes
- Ketoses, Metabolic
- 3-hydroxybutyrate
-
Aarhus, DenmarkMedical research laboratory, Department of endocrinology, Aarhus
Apr 5, 2022
Type 2 Diabetes (T2DM) Trial (Endovascular Denervation System (Netrod))
Not yet recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Endovascular Denervation System (Netrod)
- (no location specified)
Jan 5, 2023
Obesity Trial (Endobariatric procedure)
Not yet recruiting
- Obesity
- Endobariatric procedure
- (no location specified)
Aug 22, 2022
Overweight and Obesity, Type 2 Diabetes Trial in Chicago (Water, Glucose, Steviol Glycosides)
Enrolling by invitation
- Overweight and Obesity
- Type 2 Diabetes Mellitus
- Water
- +4 more
-
Naples, Florida
- +1 more
Dec 9, 2022
Diabetes, Type 1 Trial in Hellerup (glucose-dependent insulinotropic peptide, Glucose-Dependent Insulin-Releasing Hormone[3-30],
Completed
- Diabetes Mellitus, Type 1
- glucose-dependent insulinotropic peptide
- +2 more
-
Hellerup, DenmarkSteno Diabetes Center Copenhagen, Clinical Metabolic Physiology
May 5, 2021
Obesity, Abdominal Trial in Aarhus (Placebo, Cafestol)
Active, not recruiting
- Obesity, Abdominal
- Placebo
- Cafestol
-
Aarhus, Aarhus N, DenmarkSteno Diabetes Center Aarhus
Jan 4, 2023
Obesity, Diabetes, Type 2 Trial in Toronto (Dairy and plant-based dairy beverages and solids)
Completed
- Obesity
- Diabetes Mellitus, Type 2
- Dairy and plant-based dairy beverages and solids
-
Toronto, Ontario, CanadaDepartment of Nutritional Sciences, C. David Naylor Building
Jun 22, 2023
Acute Ischemic Stroke Trial in Aarhus (Semaglutide, Standard care)
Not yet recruiting
- Acute Ischemic Stroke
- Semaglutide
- Standard care
-
Aarhus, DenmarkAarhus University Hospital
Dec 9, 2022
Gastric Emptying - Implications for Pathogenesis of Type 2
Recruiting
- Diabetes Mellitus, Type 2
-
Nottingham, Notts, United KingdomDavid Greenfield Human Physiology Unit, University of Nottingham
Apr 5, 2022
Cardiovascular Risk Factor Trial in Reading (Coconut oil, Butter, Vegetable oil)
Completed
- Cardiovascular Risk Factor
- Coconut oil
- +2 more
-
Reading, Berkshire, United KingdomDepartment of Food and Nutritional Sciences, University of Readi
Feb 21, 2022
Obesity, Type 2 Diabetes, Metabolic Syndrome Trial in Boston (Dietary intervention)
Enrolling by invitation
- Obesity
- +5 more
- Dietary intervention
-
Boston, MassachusettsMassacusetts General Hospital
May 25, 2022
Healthy Trial in Singapore (Beverage powder with 12% oat bran processed with method A, Beverage powder with 12% oat bran
Completed
- Healthy
- Beverage powder with 12% oat bran processed with method A
- +4 more
-
Singapore, SingaporeNational University Hospital
Sep 20, 2022
Obesity, Weight Loss Trial in Beirut (Multidisciplinary weight loss program, Standard Care, Metformin Hcl 850Mg Tab)
Recruiting
- Obesity
- Weight Loss
- Multidisciplinary weight loss program
- +2 more
-
Beirut, Riad El Solh, LebanonAmerican University of Beirut - Medical Center
Aug 8, 2022
Individuals at Risk of Developing Diabetes Trial in Adelaide (Intermittent Fasting (IF), Daily Restriction (DR), standard care
Completed
- Individuals at Risk of Developing Diabetes
- Intermittent Fasting (IF)
- +2 more
-
Adelaide, South Australia, AustraliaUniversity of Adelaide
Dec 20, 2021
Amino Acid Trial in Bobigny (Whey Protein Isolate 894 Fonterra, Zein Sigma-Aldrich W555025, Protein-free test-meal)
Completed
- Amino Acid
- Whey Protein Isolate 894 Fonterra
- +2 more
-
Bobigny, FranceCRNH Ile de France
May 31, 2022
Type 2 Diabetes, Obesity Trial in Cambridge (0.9% Sodium-chloride, Exenatide (50ng/min for 30 minutes loading followed by
Recruiting
- Type 2 Diabetes
- Obesity
- 0.9% Sodium-chloride
- +3 more
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust and The Univ
Jan 18, 2022